Glenn A. Rockman

Glenn Rockman is Founder and Managing Partner at Adjuvant Capital. Prior to his role at Adjuvant and his efforts to finance global health R&D programs on behalf of the Bill & Melinda Gates Foundation, Mr. Rockman was an Executive Director in J.P. Morgan’s Social Finance unit. He served in similar capacities at J.P. Morgan for more than a decade before leaving to focus exclusively on financing public health innovations. Glenn Rockman is a member of the board of VitriVax, Univercells, InDevR, and Codagenix . He is also actively engaged with the Research Investment for Global Health Technology Fund (RIGHT Fund) as a board member and a champion of leveraging the strengths of South Korea’s life sciences industry to bring new public health innovations to market. Mr. Rockman earned an AB in public policy from the Princeton School of Public and International Affairs.